539P Patient-reported outcomes (PROs) from patients (Pts) with NTRK fusion-positive (NTRK-fp) solid tumours receiving entrectinib in the global phase II STARTRK-2 studyA.P. Conley,G.D. Demetri,R.C. Doebele,A. Drilon,L. Paz-Ares,P. Cassier,S. Siena,M-J. Ahn, G.L. Buchschacher,T. Seto, C.E. Chee,M. Krzakowski,S-H.I. Ou,C. Grohé, V. Zagonel,A. Spira, A. Cheng, A. Kapre, E. Piault, C.D. RolfoAnnals of Oncology（2020）引用 3|浏览48暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
